Skip to content
bd@cod-research.com
+91 79 6947 8900
+1(732) 749-7719
Request for Proposal
About Us
Our Services
Clinical Development
Global Clinical Operations
Project Management
Global Regulatory
Regulatory Services
Biometrics
Clinical Trial Data Management
Biostatistics
Global Pharmacovigilance
Medical Information Solutions
ICSR & Literature Support
Medical Safety (Aggregate, Signal, Risk Management)
PSMF & Global QPPV Solutions
Clinical Safety & AE/SAE Reporting Solutions
Quality Assurance
Good Clinical Practice (GCP)
Good Pharmacovigilance Practice (GVP)
Our Expertise
Therapy Areas
Specialties
Insights & Resources
Blogs & Articles
Case Studies
Brochures & Flyers
Webinars & Podcasts
COD Newsroom
Newsletter
Events & Conferences
Press Releases
COD Photo gallery
Careers
Contact Us
For Business Enquiries
For Conference Meetings
Connect with Experts
About Us
Our Servcies
Clinical Development
Global Clinical Operations
Project Management
Global Regulatory Affairs & Compliance Solutions
Regulatory Services
Biometrics
Clinical Trial Data Management
Biostatistics
Global Pharmacovigilance
Medical Information Solutions
ICSR & Literature Support
Medical Safety (Aggregate, Signal, Risk Management)
PSMF & Global QPPV Solutions
Clinical Safety & AE/SAE Reporting Solutions
Quality Assurance
Good Clinical Practice (GCP)
Good Pharmacovigilance Practice (GVP)
Our Expertise
Therapy Areas
Specialties
Insights & Resources
Blogs & Articles
Case Studies
Brochures & Flyers
Webinars & Podcasts
COD Newsroom
Newsletter
Events & Conferences
Press Releases
COD Photo gallery
Careers
Contact Us
For Business Enquiries
For Conference Meetings
Connect with Experts
Insights & Resources
Home
|
Insights & Resources
Clinical Trials
Pharmacovigilance
Regulatory
Corporate Presentation
Quality Assurance
Flyer
Medical Affairs
Read More
Flyer
CT Quality Assurance
Read More
Flyer
Clinical Services
Read More
Flyer
Biometrics
Read More
Transforming Complexity into Success: A Large-Scale Global Phase III Biosimilar Dermatology Trial
Read More
Blog
Strategic Planning for Patient Recruitment
Read More
Article
Pulmonary Disease Introduction: Prevalence, Causes, Prevention & Treatment
Read More
EMA
FDA
MHRA
Summary of the Medicine Shortages SPOC Working Party meeting on 17 June 2025
Source: EMA
Published on 2025-07-29
Nitrosamine impurities
Source: EMA
Published on 2025-07-29
Report: European medicines regulatory network’s response to nitrosamine impurities in human medicines
Source: EMA
Published on 2025-07-29
Human medicines European public assessment report (EPAR): Osvyrti, denosumab, Date of authorisation: 26/05/2025, Status: Authorised
Source: EMA
Published on 2025-07-28
Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Date of authorisation: 15/11/2021, Revision: 10, Status: Authorised
Source: EMA
Published on 2025-07-28
Human medicines European public assessment report (EPAR): Jubereq, denosumab, Date of authorisation: 26/05/2025, Status: Authorised
Source: EMA
Published on 2025-07-28
Read More
FDA approves pembrolizumab for adenocarcinoma
Source: FDA
Published on 2025-04-08
Approved Drug Products with Therapeutic Equivalence Evaluations (Orang
Source: FDA
Published on 2025-04-08
Additions/Deletions for Prescription and OTC Drug Product Lists
Source: FDA
Published on 2025-04-08
Recalls small number of acne products for benzene contamination
Source: FDA
Published on 2025-04-08
FDA Drug Shortages
Source: FDA
Published on 2025-04-08
FDA Drug Shortages
Source: FDA
Published on 2025-04-08
Read More
Updated guidance on the management of the recalled Endologix Nellix EndoVascular Aneurysm Sealing (EVAS) System (DSI/2025/004)
Source: MHRA
Published on 2025-07-28
Class 2 Medicines Recall: ChloraPrep 1mL Clear Sterile Solution/Applicator, Becton Dickinson UK Ltd, EL(25)A/36
Source: MHRA
Published on 2025-07-28
Class 2 Medicines Recall: Flutiform 250 micrograms / 10 micrograms per actuation pressurised inhalation, suspension , CD Pharma Ltd, EL(25)A/35
Source: MHRA
Published on 2025-07-24
Trinity Biotech Premier Hb9210™ HbA1c Analyser: Risk of Positive Bias and Updates to Instructions for Use (IFU), including use as a diagnostic aid in diabetes mellitus (DSI/2025/003)
Source: MHRA
Published on 2025-07-22
Field Safety Notices: 14 to 18 July 2025
Source: MHRA
Published on 2025-07-22
Field Safety Notices: 7 to 11 July 2025
Source: MHRA
Published on 2025-07-21
Read More